Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 717318, 8 pages
http://dx.doi.org/10.1155/2014/717318
Research Article

Serum and Urinary NGAL in Septic Newborns

1Department of Neonatal Intensive Care, Upper Silesian Centre of Child’s Health, Medical University of Silesia, Ul. Medykow 16, 40-752 Katowice, Poland
2Department of Pathophysiology, Medical University of Silesia, Ul. Medykow 18, 40-752 Katowice, Poland

Received 30 April 2013; Revised 29 September 2013; Accepted 25 October 2013; Published 21 January 2014

Academic Editor: Marlies Ostermann

Copyright © 2014 Mike Smertka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Mehta, J. A. Kellum, S. V. Shah et al., “Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury,” Critical Care, vol. 11, no. 2, p. R31, 2007. View at Google Scholar · View at Scopus
  2. R. Koralkar, N. Ambalavanan, E. B. Levitan, G. McGwin, S. Goldstein, and D. Askenazi, “Acute kidney injury reduces survival in very low birth weight infants,” Pediatric Research, vol. 69, no. 4, pp. 354–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. G. Jetton and D. J. Askenazi, “Update on acute kidney injury in the neonate,” Current Opinion in Pediatrics, vol. 24, no. 2, pp. 191–196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Smertka and J. Chudek, “Using NGAL as an early diagnostic test of acute kidney injury,” Renal Failure, vol. 34, no. 1, pp. 130–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Devarajan, “Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury,” Biomarkers in Medicine, vol. 4, no. 2, pp. 265–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Axelsson, M. Bergenfeldt, and K. Ohlsson, “Studies of the release and turnover of a human neutrophil lipocalcin,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 55, no. 7, pp. 577–588, 1995. View at Google Scholar · View at Scopus
  7. T. Breidthardt, M. Christ-Crain, D. Stolz et al., “A combined cardiorenal assessment for the prediction of acute kidney injury in lower respiratory tract infections,” The American Journal of Medicine, vol. 125, no. 2, pp. 168–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A.-S. C. Decavele, L. Dhondt, M. L. de Buyzere, and J. R. Delanghe, “Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 6, pp. 999–1003, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. P. Lavery, J. K. Meinzen-Derr, E. Anderson et al., “Urinary NGAL in premature infants,” Pediatric Research, vol. 64, no. 4, pp. 423–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Wasilewska, K. Taranta-Janusz, W. Dȩbek, W. Zoch-Zwierz, and E. Kuroczycka-Saniutycz, “KIM-1 and NGAL: new markers of obstructive nephropathy,” Pediatric Nephrology, vol. 26, no. 4, pp. 579–586, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Inoue, S. Ohga, T. Kusuda et al., “Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants,” Early Human Development, vol. 89, no. 6, pp. 425–429, 2013. View at Google Scholar
  12. M. H. Biezeveld, G. van Mierlo, R. Lutter et al., “Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases,” Clinical and Experimental Immunology, vol. 141, no. 1, pp. 183–188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Boubred, I. Grandvuillemin, and U. Simeoni, “Pathophysiology of fetal and neonatal kidneys,” in NeonaTology: A Practical Approach to Neonatal Diseases, G. Bouonocore, R. Bracci, and M. Weindling, Eds., pp. 1018–1026, Springer, Milan, Italy, 2012. View at Google Scholar
  14. H. Finney, D. J. Newman, H. Thakkar, J. M. E. Fell, and C. P. Price, “Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children,” Archives of Disease in Childhood, vol. 82, no. 1, pp. 71–75, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Harmoinen, E. Ylinen, M. Ala-Houhala, M. Janas, M. Kaila, and T. Kouri, “Reference intervals for cystatin C in pre- and full-term infants and children,” Pediatric Nephrology, vol. 15, no. 1-2, pp. 105–108, 2000. View at Google Scholar · View at Scopus
  16. A. C. D. A. C. F. Novo, L. D. S. R. Sadeck, T. S. Okay, and C. R. Leone, “Longitudinal study of cystatin C in healthy term newborns,” Clinics, vol. 66, no. 2, pp. 217–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Treiber, B. P. Balon, and M. Gorenjak, “Cystatin C versus creatinine as a marker of glomerular filtration rate in the newborn,” Wiener Klinische Wochenschrift, vol. 118, supplement 2, pp. 66–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Nejat, J. W. Pickering, R. J. Walker, and Z. H. Endre, “Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit,” Nephrology Dialysis Transplantation, vol. 25, no. 10, pp. 3283–3289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Mårtensson, C.-R. Martling, A. Oldner, and M. Bell, “Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients,” Nephrology Dialysis Transplantation, vol. 27, no. 2, pp. 576–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Maruniak-Chudek, T. Owsianka-Podlesny, J. Wroblewska, and D. Jadamus-Niebroj, “Is serum cystatin C a better marker of kidney function than serum creatinine in septic newborns?” Postępy Higieny i Medycyny Doświadczalnej, vol. 66, pp. 175–180, 2012. View at Google Scholar
  21. C. R. Parikh, P. Devarajan, M. Zappitelli et al., “Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery,” Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1737–1747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Bennett, C. L. Dent, Q. Ma et al., “Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 3, pp. 665–673, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Bagshaw, M. Bennett, P. Devarajan, and R. Bellomo, “Urine biochemistry in septic and non-septic acute kidney injury: a prospective observational study,” Journal of Critical Care, vol. 28, no. 4, pp. 371–378. View at Publisher · View at Google Scholar
  24. M. Aydoğdu, G. Gürsel, B. Sancak et al., “The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients,” Disease Markers, vol. 34, no. 4, pp. 237–246, 2013. View at Google Scholar
  25. M. di Nardo, A. Ficarella, Z. Ricci et al., “Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study,” Blood Purification, vol. 35, no. 1–3, pp. 172–176, 2013. View at Google Scholar
  26. D. Katagiri, K. Doi, T. Matsubara et al., “New biomarker panel of plasma neutrophil gelatinase-associated lipocalin and endotoxin activity assay for detecting sepsis in acute kidney injury,” Journal of Critical Care, vol. 28, no. 5, pp. 564–570, 2013. View at Publisher · View at Google Scholar
  27. G. P. Otto, M. Busch, M. Sossdorf, and R. A. Claus, “Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis,” Critical Care, vol. 17, no. 2, p. 419, 2013. View at Google Scholar
  28. A. Romanovsky, C. Morgan, and S. M. Bagshaw, “Pathophysiology and management of septic acute kidney injury,” Pediatric Nephrology, vol. 29, no. 1, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  29. M. Mussap, A. Noto, M. Fravega, and V. Fanos, “Urine neutrophil gelatinase-associated lipocalin (uNGAL) and netrin-1: are they effectively improving the clinical management of sepsis-induced acute kidney injury (AKI)?” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, supplement 2, pp. 15–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. J. Glassford, A. G. Schneider, S. Xu et al., “The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury,” Intensive Care Medicine, vol. 39, no. 10, pp. 1714–1724, 2013. View at Publisher · View at Google Scholar
  31. J. Mårtensson, S. Xu, M. Bell, C. R. Martling, and P. Venge, “Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils,” Clinica Chimica Acta, vol. 413, no. 19-20, pp. 1661–1667, 2012. View at Google Scholar